BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 21257259)

  • 1. Green tea epigallocatechin gallate enhances therapeutic efficacy of temozolomide in orthotopic mouse glioblastoma models.
    Chen TC; Wang W; Golden EB; Thomas S; Sivakumar W; Hofman FM; Louie SG; Schönthal AH
    Cancer Lett; 2011 Mar; 302(2):100-8. PubMed ID: 21257259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The unfolded protein response regulator GRP78/BiP as a novel target for increasing chemosensitivity in malignant gliomas.
    Pyrko P; Schönthal AH; Hofman FM; Chen TC; Lee AS
    Cancer Res; 2007 Oct; 67(20):9809-16. PubMed ID: 17942911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chloroquine enhances temozolomide cytotoxicity in malignant gliomas by blocking autophagy.
    Golden EB; Cho HY; Jahanian A; Hofman FM; Louie SG; Schönthal AH; Chen TC
    Neurosurg Focus; 2014 Dec; 37(6):E12. PubMed ID: 25434381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptional targeting of adenovirally delivered tumor necrosis factor alpha by temozolomide in experimental glioblastoma.
    Yamini B; Yu X; Gillespie GY; Kufe DW; Weichselbaum RR
    Cancer Res; 2004 Sep; 64(18):6381-4. PubMed ID: 15374943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperoxia resensitizes chemoresistant glioblastoma cells to temozolomide through unfolded protein response.
    Lee D; Sun S; Ho AS; Kiang KM; Zhang XQ; Xu FF; Leung GK
    Anticancer Res; 2014 Jun; 34(6):2957-66. PubMed ID: 24922660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of glioblastoma cell killing by combination treatment with temozolomide and tamoxifen or hypericin.
    Gupta V; Su YS; Wang W; Kardosh A; Liebes LF; Hofman FM; Schönthal AH; Chen TC
    Neurosurg Focus; 2006 Apr; 20(4):E20. PubMed ID: 16709026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gain of function of mutant TP53 in glioblastoma: prognosis and response to temozolomide.
    Wang X; Chen JX; Liu JP; You C; Liu YH; Mao Q
    Ann Surg Oncol; 2014 Apr; 21(4):1337-44. PubMed ID: 24248532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of chemotherapy-induced DNA repair on oncolytic herpes simplex viral replication.
    Aghi M; Rabkin S; Martuza RL
    J Natl Cancer Inst; 2006 Jan; 98(1):38-50. PubMed ID: 16391370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EGCG inhibits properties of glioma stem-like cells and synergizes with temozolomide through downregulation of P-glycoprotein inhibition.
    Zhang Y; Wang SX; Ma JW; Li HY; Ye JC; Xie SM; Du B; Zhong XY
    J Neurooncol; 2015 Jan; 121(1):41-52. PubMed ID: 25173233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A stapled peptide antagonist of MDM2 carried by polymeric micelles sensitizes glioblastoma to temozolomide treatment through p53 activation.
    Chen X; Tai L; Gao J; Qian J; Zhang M; Li B; Xie C; Lu L; Lu W; Lu W
    J Control Release; 2015 Nov; 218():29-35. PubMed ID: 26428461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temozolomide and other potential agents for the treatment of glioblastoma multiforme.
    Nagasawa DT; Chow F; Yew A; Kim W; Cremer N; Yang I
    Neurosurg Clin N Am; 2012 Apr; 23(2):307-22, ix. PubMed ID: 22440874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Status quo--standard-of-care medical and radiation therapy for glioblastoma.
    Becker KP; Yu J
    Cancer J; 2012; 18(1):12-9. PubMed ID: 22290252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Effect of Ascorbic Acid over the Etoposide- and Temozolomide-Mediated Cytotoxicity in Glioblastoma Cell Culture: A Molecular Study.
    Gokturk D; Kelebek H; Ceylan S; Yilmaz DM
    Turk Neurosurg; 2018; 28(1):13-18. PubMed ID: 28191621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Achievable Central Nervous System Concentrations of the Green Tea Catechin EGCG Induce Stress in Glioblastoma Cells in Vitro.
    Grube S; Ewald C; Kögler C; Lawson McLean A; Kalff R; Walter J
    Nutr Cancer; 2018 Oct; 70(7):1145-1158. PubMed ID: 30198785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term therapy with temozolomide is a feasible option for newly diagnosed glioblastoma: a single-institution experience with as many as 101 temozolomide cycles.
    Barbagallo GM; Paratore S; Caltabiano R; Palmucci S; Parra HS; Privitera G; Motta F; Lanzafame S; Scaglione G; Longo A; Albanese V; Certo F
    Neurosurg Focus; 2014 Dec; 37(6):E4. PubMed ID: 25434389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined cimetidine and temozolomide, compared with temozolomide alone: significant increases in survival in nude mice bearing U373 human glioblastoma multiforme orthotopic xenografts.
    Lefranc F; James S; Camby I; Gaussin JF; Darro F; Brotchi J; Gabius J; Kiss R
    J Neurosurg; 2005 Apr; 102(4):706-14. PubMed ID: 15871514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concomitant and adjuvant temozolomide of newly diagnosed glioblastoma in elderly patients.
    Behm T; Horowski A; Schneider S; Bock HC; Mielke D; Rohde V; Stockhammer F
    Clin Neurol Neurosurg; 2013 Oct; 115(10):2142-6. PubMed ID: 23993314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Temozolomide in patients with a glioblastoma multiforme: new developments].
    Bromberg JE; Postma TJ
    Ned Tijdschr Geneeskd; 2005 Jun; 149(25):1376-8. PubMed ID: 15997689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trans-sodium crocetinate enhancing survival and glioma response on magnetic resonance imaging to radiation and temozolomide.
    Sheehan J; Cifarelli CP; Dassoulas K; Olson C; Rainey J; Han S
    J Neurosurg; 2010 Aug; 113(2):234-9. PubMed ID: 20001586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial.
    Stupp R; Hegi ME; Mason WP; van den Bent MJ; Taphoorn MJ; Janzer RC; Ludwin SK; Allgeier A; Fisher B; Belanger K; Hau P; Brandes AA; Gijtenbeek J; Marosi C; Vecht CJ; Mokhtari K; Wesseling P; Villa S; Eisenhauer E; Gorlia T; Weller M; Lacombe D; Cairncross JG; Mirimanoff RO; ;
    Lancet Oncol; 2009 May; 10(5):459-66. PubMed ID: 19269895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.